Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 July 2022 | Story Lunga Luthuli

From an early age, many have been taught that strangers are not only a danger to the individual, but to the communities too.

A StrangerKind (ASK), an organisation hosting unconventional conversations in communities on topics and responding to questions that many may not have the opportunity to ask, has partnered with the University of the Free State to host the talks that aims to promote curiosity, diversity, and social cohesion.

As part of the ASKcampus – a first to be hosted at any university in the country – participants will have an opportunity to talk to a stranger in a safe setting and ask any question that comes to mind, without any judgement.

Michelle Nöthling, Assistant Researcher in Kovsie Support Services, said: “The ASK event is an opportunity for participants to pick a topic from a list that sparks curiosity and book an available 45-minute time slot. During your session, you sit down to a one-on-one conversation with a stranger who will briefly introduce themselves and their topic. They will then share their personal life experience on that topic with you.”

The event, which will be launched at the Thakaneng Bridge, Bloemfontein Campus, on 28 July 2022, is open to both UFS staff and students.

“During the individual sessions, participants may ask the strangers anything about the chosen topic. We even encourage you to ask those questions that you might otherwise have been too shy, or felt were too ignorant, to ask. What is more, is that the strangers you will meet will be fellow UFS staff and students. But you will not know who your stranger is until you sit down with them,” said Michelle.

Individuals who want to know more about becoming a UFS stranger are encouraged to visit the organisation’s YouTube channel or register to attend training and become a ‘stranger’.

Be curious. Be brave. Talk to strangers.

Launch details:
Date
: 28 July 2022
Time
: 10:00-14:00
Venue
: Thakaneng Bridge, Bloemfontein Campus

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept